Bio-Techne Launches Cultrex™ Synthetic Hydrogel to Enhance Reproducibility in 3D Organoid Culture
Exhibitor: HONG JING CO., LTD.
Date: 2026-05-11
Booth No.: M1028
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-Techne announced the launch of Cultrex™ Synthetic Hydrogel, a fully defined synthetic extracellular matrix (ECM), expanding its established Cultrex™ ECM portfolio and providing researchers with a more reproducible and scalable solution for 3D stem cell and organoid culture workflows.
Cultrex™ Synthetic Hydrogel is designed to reduce lot-to-lot variability commonly associated with traditional biologically derived matrices. By offering a fully defined composition, it enables more consistent experimental conditions across studies and laboratories, improving reproducibility and data reliability in 3D culture systems.
The product supports a broad range of organoid applications, including drug screening, toxicology studies, and personalized medicine research, while reducing reliance on animal-derived matrices and supporting the adoption of New Approach Methodologies (NAMs).
From a regulatory perspective, Cultrex™ Synthetic Hydrogel aligns with FDA initiatives aimed at improving translational predictability by enabling more robust and standardized preclinical models. Its defined composition supports consistency, traceability, and scalability for workflows advancing toward regulatory-facing studies.
Will Geist, President of the Protein Sciences Segment at Bio-Techne, commented:
“This product reflects the evolving needs of researchers as stem cell and organoid models move more quickly from discovery into translational workflows. Cultrex™ Synthetic Hydrogel expands our ECM portfolio with a fully defined, scalable solution that enhances reproducibility and consistency without compromising performance.”
This launch further strengthens Bio-Techne’s comprehensive Cultrex™ portfolio, which includes Basement Membrane Extracts (BME), recombinant proteins, cytokines and growth factors, AI-modified proteins, small molecules, media, and supplements—offering researchers a complete toolbox for 3D culture applications.
As the authorized Bio-Techne distributor in Taiwan, HongJin Co., Ltd. continues to support local researchers with Cultrex™ ECM products and 3D stem cell and organoid culture solutions, providing technical support and application guidance to accelerate research in regenerative medicine, drug discovery, and translational science.
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08